Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sancho Calabuig

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Atencion Primaria|February 12, 1998
[Ranitidine and a rare adverse reaction: urticaria]A Sancho Calabuig, V Palop Larrea, E López González, et al.
Atencion Primaria|January 1, 1997
[Topical antihistamines. Till when?]J M López Martín, C Catalán Oliver, E López González, et al.
Lancet (London, England)|December 24, 1998
Vasculitis with acute kidney failure and torasemideV Palop-Larrea, A Sancho-Calabuig, J L Gorriz-Teruel, et al.
Transplantation Proceedings|September 1, 2009
Use of basiliximab induction in low-immunological risk renal transplant recipients receiving tacrolimus-based immunosuppressionE Gavela Martínez, A I Avila Bernabeu, A Sancho Calabuig, et al.
Transplantation Proceedings|February 4, 2015
Safety and efficacy of induction treatment with low thymoglobulin doses in kidney transplantation from expanded-criteria donorsA Sancho Calabuig, E Gavela Martínez, J Kanter Berga, et al.
Transplantation Proceedings|September 1, 2009
Very low-grade proteinuria at 3 months posttransplantation is an earlier marker of graft survivalA Sancho Calabuig, L M Pallardó Mateu, A I Avila Bernabeu, et al.
Transplantation Proceedings|October 26, 2010
Vitamin D deficiency in a renal transplant population: safe repletion with moderate doses of calcidiolJ Kanter Berga, J Crespo Albiach, S Beltran Catalan, et al.
Transplantation Proceedings|August 16, 2011
Delayed graft function after renal transplantation: an unresolved problemE Gavela Martínez, L M Pallardó Mateu, A Sancho Calabuig, et al.
Transplantation Proceedings|August 16, 2011
Donor-specific HLA antibodies: risk factors and outcomes after kidney transplantationJ Kanter Berga, L M Pallardo Mateu, S Beltran Catalan, et al.
Transplantation Proceedings|December 10, 2016
Desensitization Protocol in Recipients of Deceased Kidney Donor With Donor-Specific Antibody-Low TitersJ Kanter Berga, A Sancho Calabuig, E Gavela Martinez, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Atencion Primaria|February 12, 1998
[Ranitidine and a rare adverse reaction: urticaria]A Sancho Calabuig, V Palop Larrea, E López González, et al.
Atencion Primaria|January 1, 1997
[Topical antihistamines. Till when?]J M López Martín, C Catalán Oliver, E López González, et al.
Lancet (London, England)|December 24, 1998
Vasculitis with acute kidney failure and torasemideV Palop-Larrea, A Sancho-Calabuig, J L Gorriz-Teruel, et al.
Transplantation Proceedings|September 1, 2009
Use of basiliximab induction in low-immunological risk renal transplant recipients receiving tacrolimus-based immunosuppressionE Gavela Martínez, A I Avila Bernabeu, A Sancho Calabuig, et al.
Transplantation Proceedings|February 4, 2015
Safety and efficacy of induction treatment with low thymoglobulin doses in kidney transplantation from expanded-criteria donorsA Sancho Calabuig, E Gavela Martínez, J Kanter Berga, et al.
Transplantation Proceedings|September 1, 2009
Very low-grade proteinuria at 3 months posttransplantation is an earlier marker of graft survivalA Sancho Calabuig, L M Pallardó Mateu, A I Avila Bernabeu, et al.
Transplantation Proceedings|October 26, 2010
Vitamin D deficiency in a renal transplant population: safe repletion with moderate doses of calcidiolJ Kanter Berga, J Crespo Albiach, S Beltran Catalan, et al.
Transplantation Proceedings|August 16, 2011
Delayed graft function after renal transplantation: an unresolved problemE Gavela Martínez, L M Pallardó Mateu, A Sancho Calabuig, et al.
Transplantation Proceedings|August 16, 2011
Donor-specific HLA antibodies: risk factors and outcomes after kidney transplantationJ Kanter Berga, L M Pallardo Mateu, S Beltran Catalan, et al.
Transplantation Proceedings|December 10, 2016
Desensitization Protocol in Recipients of Deceased Kidney Donor With Donor-Specific Antibody-Low TitersJ Kanter Berga, A Sancho Calabuig, E Gavela Martinez, et al.
Pageof 2